Home

Kathleen A. Rickard

CIK 1836883 · Chief Medical Officer · last filed 2025-10-08

Kathleen A. Rickard is a Chief Medical Officer who has filed 38 SEC Form 4 insider transactions across 1 company since 2021. The most recent filing, for VRNA, was dated Oct 8, 2025. Across all open-market trades the lifetime net is −$5.7M, making them a net seller over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

38

Lifetime Open-Market Net

-$5.68M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Verona Pharma plc (VRNA) Delisted Chief Medical Officer 0 $106.91 $0 -$5.68M 31 2025-10-08

Recent Filings

38 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2025-10-08 Verona Pharma plc (VRNA) Delisted Mixed −2,432,868 $0 EDGAR
2025-09-03 Verona Pharma plc (VRNA) Delisted Gift (G) −189,600 $0 EDGAR
2025-08-05 Verona Pharma plc (VRNA) Delisted Mixed +12,552 -$766.8K EDGAR
2025-07-09 Verona Pharma plc (VRNA) Delisted Mixed +48,448 -$430.4K EDGAR
2025-05-08 Verona Pharma plc (VRNA) Delisted Sell (S) −114,984 -$1.01M EDGAR
2025-05-06 — Notice (144) −14,373 -$1.04M EDGAR
2025-05-05 Verona Pharma plc (VRNA) Delisted Mixed +800 -$440.3K EDGAR
2025-05-01 Verona Pharma plc (VRNA) Delisted Mixed +51,680 -$308.8K EDGAR
2025-03-13 Verona Pharma plc (VRNA) Delisted Sell (S) −79,264 -$661.9K EDGAR
2025-03-12 — Notice (144) −9,908 -$621.2K EDGAR
Showing 1–10 of 38
Page 1 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.